Cargando…
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
BACKGROUND: The mortality rate of Coronavirus disease 2019 (COVID-19) is extremely high in hemodialysis patients (HDP). These patients also develop lower antibody titers after vaccination. Therefore, factors associated with antibody titers and vaccine efficacy in HDP with breakthrough infection need...
Autores principales: | Toda, Masataro, Yoshifuji, Ayumi, Kikuchi, Kan, Koinuma, Masayoshi, Komatsu, Motoaki, Fujii, Kentaro, Kato, Ai, Kikuchi, Takahide, Nakazawa, Atsushi, Ryuzaki, Munekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824537/ https://www.ncbi.nlm.nih.gov/pubmed/35133533 http://dx.doi.org/10.1007/s10157-022-02188-y |
Ejemplares similares
-
Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022) -
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
por: Toda, Masataro, et al.
Publicado: (2022) -
Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023) -
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021) -
A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma
por: Kato, Ai, et al.
Publicado: (2022)